This inventor holds 1 USPTO granted patent. Top assignee: Other. Active years: 2016.
Company Filing History:
1 out of 834,350 Years Active: 2016
Title: Mark Ruschin: Innovator in Radiotherapy Quality Assurance
Introduction
Mark Ruschin is a notable inventor based in Toronto, Canada. He has made significant contributions to the field of radiotherapy through his innovative designs and patents. His work focuses on enhancing patient-specific quality assurance in arc-based radiotherapy.
Latest Patents
Mark Ruschin holds a patent for a "Multi-modality dosimeter for use with arc-based radiotherapy quality assurance phantom." This dosimeter is designed to assist in acquiring multiple dosimetric measurements simultaneously. It is particularly useful in stereotactic radiotherapy, facilitating measurements from various modalities, including gel dosimetry and film dosimetry. The dosimeter is also configured for simultaneous use with a diode-array QA phantom.
Career Highlights
Throughout his career, Mark has demonstrated a commitment to improving radiotherapy practices. His innovative approach has led to advancements in quality assurance processes, ultimately benefiting patient care. He has been recognized for his contributions to the field and continues to work on enhancing radiotherapy technologies.
Collaborations
Mark Ruschin has collaborated with notable professionals in his field, including David Beachey and Ian Parkinson. These collaborations have further enriched his work and contributed to the development of effective radiotherapy solutions.
Conclusion
Mark Ruschin is a distinguished inventor whose work in radiotherapy quality assurance has made a significant impact. His innovative dosimeter and collaborative efforts highlight his dedication to advancing medical technology.